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Poly-c-glutamic acid (c-PGA) is a naturally occurring biopolymer made up of repeating units of
L-glutamic acid, D-glutamic acid or both. c-PGA can exhibit different properties (conformational
states, enantiomeric properties and molecular mass). Owing to its biodegradable, non-toxic and
non-immunogenic properties, it has been used successfully in the food, medical and wastewater
industries. Amongst other novel applications, it has the potential to be used for protein
crystallization, as a soft tissue adhesive and a non-viral vector for safe gene delivery. This review
focuses on the production, properties and applications of c-PGA. Each application of c-PGA
utilizes specific properties attributed to various forms of c-PGA. As a result of its growing
applications, more strains of bacteria need to be investigated for c-PGA production to obtain high
yields of c-PGA with different properties. Many medical applications (especially drug delivery)
have exploited a-PGA. As c-PGA is essentially different from a-PGA (i.e. it does not involve a
chemical modification step and is not susceptible to proteases), it could be better utilized for such
medical applications. Optimization of c-PGA with respect to cost of production, molecular mass
and conformational/enantiomeric properties is a major step in making its application practical.
Analyses of c-PGA production and knowledge of the enzymes and genes involved in c-PGA
production will not only help increase productivity whilst reducing the cost of production, but also
help to understand the mechanism by which c-PGA is effective in numerous applications.
Introduction
Polyglutamic acid (PGA) is a biodegradable, non-immuno-
genic and unusual anionic homopolyamide that is made of
D- and L-glutamic acid units (Shih & Van, 2001) (Fig. 1).
PGA can be differentiated into two isoforms, a-PGA and c-
PGA, depending on the attachment of the carboxy group
(a and c, respectively). a-PGA is synthesized chemically
by nucleophile-initiated polymerization of the c-protected
N-carboxyanhydride of L-glutamic acid. Microbial pro-
duction of a-PGA is difficult and the polymer can only
be produced by recombinant technology (Buescher &
Margaritis, 2007). c-PGA has been produced extensively
using bacteria, especially those of Bacillus species. It can
either be composed of only L-glutamic acid residues (c-L-
PGA), only D-glutamic acid residues (c-D-PGA) or both
L- and D-glutamic acid residues (c-LD-PGA). c-PGA
is different from other proteins, because glutamate is
polymerized inside the cell via the c-amide linkages and
thus is synthesized in a ribosome-independent manner
(Akagi et al., 2007; Bodna´r et al., 2008). Hence, substances
that inhibit translation of proteins, such as chlorampheni-
col, have no effect on the production of c-PGA. Due to the
c-linkage of its component glutamate residues, c-PGA is
resistant to proteases, which cleave a-amino linkages
(Candela & Fouet, 2006). c-PGA can exist either in the
water-insoluble free acid form or as its salt with a variety
of cations (Na+, Mg2+, K+, NH4
+ or Ca2+), which is
completely soluble.
c-PGA was first discovered by Ivonovics and Bruckner
(1937a, b) when a capsule of Bacillus anthracis was released
into the medium upon autoclaving (Shih & Van, 2001).
Another naturally occurring source of c-PGA is the mucilage
of natto (fermented soybeans – a traditional food in Japan),
which contains a mixture of c-PGA and fructan produced
by Bacillus subtilis Sawamura (Shih & Van, 2001; Candela &
Fouet, 2006). c-PGA is produced mostly by Gram-
positive bacteria, which include the genus Bacillus. It
has also been reported that at least one Gram-negative
bacterium (Fusobacterium nucleatum), some archaea and
eukaryotes have the ability to produce c-PGA (Candela et al.,
2009; Weber, 1990; Hezayen et al., 2001). c-PGA has also
been found in neurons of mice where it was covalently
Abbreviations: GGT, c-glutamyl-transpeptidase; GPC, gel permeation
chromatography; NK, natural killer; NP, nanoparticle; PEC, polyelectro-
lyte complex; PGA, polyglutamic acid.
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linked to tubulin (Edde´ et al., 1990). Efforts have been made
to insert the genes responsible for c-PGA production into
Escherichia coli and plants such as tobacco to gain more
knowledge regarding the molecular mechanism of c-PGA
production (Ashiuchi et al., 1999a; Tarui et al., 2005), and
pgsB, pgsC and pgsA genes were identified as essential for its
production. Recently, Cao et al. (2013) also cloned and co-
expressed the pgsBCA genes and glutamate racemase gene
(racE/glr) into E. coli, and reported that the engineered E.
coli strains had the ability to synthesize c-PGA with excellent
D-glutamate content due to racE integration. Here, we
provide a brief updated review on the production, properties
and applications of bacterially produced c-PGA, and give a
brief summary of the mechanism of synthesis of c-PGA.
Function of c-PGA
Why do organisms produce c-PGA? The function of c-PGA
depends on the organism producing it and the envir-
onment the organism inhabits. The function also depends
on whether the c-PGA is peptidoglycan bound or released.
If the c-PGA is peptidoglycan bound, it may help confer
virulence or it can act as a source of glutamate under
conditions of starvation (Kimura et al., 2004; Kocianova
et al., 2005). If it is released into the environment, c-PGA
can help the organism survive under adverse conditions
(McLean et al., 1990).
It has been shown that the capsules of virulent strains of B.
anthracis contain solely c-D-PGA (Tomcsik & Szongott,
1933 in Candela & Fouet, 2006). The D enantiomer in B.
anthracis capsule makes the bacterium non-immunogenic
(Zwartouw & Smith, 1956). The c-PGA protects the
bacterial cells against phage infections and also prevents
antibodies from gaining access to the bacterium (Mesnage
et al., 1998). Likewise, Staphylococcus epidermidis also
synthesizes surface-associated c-PGA (Kocianova et al.,
2005), which protects it against antimicrobial peptides. In
both cases, c-PGA helps the pathogenic bacteria to escape
phagocytosis, hence contributing to virulence. In some
cases, c-PGA also acts as a source of glutamate when bacteria
are starved in the late stationary phase (Kimura et al., 2004).
Unlike B. anthracis, certain soil bacteria release c-PGA into
the environment for the sequestration of toxic metal ions,
increasing their resistance to adverse environments (McLean
et al., 1990). Planococcus halophilus, Sporosarcina halophila
and Natrialba aegyptiaca specifically use c-PGA to decrease
high local salt concentrations, which helps them to survive
in hostile environments (Kandler et al., 1983; Hezayen et al.,
2001). Eukaryotic organisms such as Cnidaria are also
known to produce c-PGA. These marine animals have
nematocysts (stinging cells) that they use explosively for prey
capture, locomotion and protection. Large amounts of c-
PGA help to trigger this explosive reaction (Weber, 1990).
As mentioned earlier, the presence of c-PGA has also been
shown in neurons of mice (Edde´ et al., 1990) where it is
thought to play a role in the regulation of microtubule
dynamics by modifying the interaction of tubulin with
tubulin-associated proteins and Ca2+ (Edde´ et al., 1990).
Bacillus amyloliquefaciens C06 uses c-PGA to improve both
its ability to form biofilm and motility, by causing cells
to stick together in a coordinated pattern and absorbing
essential nutrients needed for motility from the envir-
onment, respectively (Liu et al., 2010).
Mechanism of synthesis of c-PGA
One of the major challenges of making c-PGA usage
applicable in industry is its cost. According to Sung et al.
(2005b), c-PGA is several tens to hundreds fold more
expensive than the conventional materials it is envisioned
to replace. Reducing the cost of production is the only
foreseeable solution to this problem. Designing mass
production systems for c-PGA would be a major step
towards a potent solution. To achieve this, one needs to
obtain thorough knowledge of how different factors affect
the yield of production. Information about genes and
enzymes involved in c-PGA production would certainly
help in manipulating organisms for more efficient pro-
duction of c-PGA.
The past 15 years have seen a rise in research in this
direction (Ashiuchi & Misono, 2002; Sung et al., 2005b;
Candela & Fouet, 2006; Buescher & Margaritis, 2007) and
genes that play a role in every step of c-PGA production
have been identified. This section attempts to provide an
understanding of the current knowledge of the mechanism
of c-PGA synthesis.
A biosynthetic pathway for the production of c-PGA has
been proposed (Fig. 2). L-Glutamic acid units that make up
c-PGA can be derived from two sources. They can be
obtained via the glutamic acid biosynthetic pathway either
exogenously or endogenously. Endogenous production of
L-glutamic acid requires conversion of a carbon source via
acetyl-CoA and TCA cycle intermediates. a-Ketoglutaric
acid from the TCA cycle serves as a direct precursor of
glutamic acid synthesis (Ko & Gross, 1998; Rehm, 2009).
Exogenous L-glutamic acid can be converted to L-
glutamine with the help of the enzyme glutamine synthase.
L-Glutamine is a precursor of c-PGA as well. The process of
c-PGA synthesis can be seen to have four distinct stages: c-
PGA racemization, c-PGA polymerization, c-PGA regu-
lation and c-PGA degradation.
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Fig. 1. Structure of c-PGA.
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c-PGA racemization
As mentioned earlier, c-PGA can have L, D or both L and D
enantiomers of glutamic acid in varying amounts. To
incorporate D-glutamic acid into the growing chain of
c-PGA, it needs to be obtained from L-glutamic acid
(exogenously supplied or produced de novo) by a racem-
ization reaction.
B. subtilis has two homologues of the glutamate racemase
gene, racE/glr and yrpC (Ashiuchi et al., 1998, 1999b). The
functions of these genes are still uncertain as there are
differing reports on the importance of each gene (Ashiuchi
et al., 2003b; Kada et al., 2004; Kimura et al., 2004). RacE is
a cytosolic enzyme with a high selectivity for glutamic acid
and a preference for L-glutamic acid (Thorne et al., 1955;
Buescher & Margaritis, 2007). According to Kimura et al.
(2004), racE was only important for growth in complex
medium, whereas yrpC was found to be active when cells
were grown on minimal medium. Neither of the two
glutamate racemase genes was found to be responsible for
the synthesis of c-PGA even though both seemed essential
for D-glutamate catabolism (Kimura et al., 2004).
On the contrary, Kada et al. (2004) found glr to be essential
for converting L-glutamate into D-glutamate for the
synthesis of c-PGA and peptidoglycan as well as growth
in B. subtilis. Research has, however, shown that Mn2+
affects the enantiomeric composition of c-PGA (Cromwick
& Gross, 1995a, b; Pe´rez-Camero et al., 1999; Wu et al.,
2006). Ashiuchi et al. (2004) showed that Mn2+ affected
the enantiomeric composition by altering the expression of
the glr gene. The ratio between L- and D-glutamate in
Bacillus licheniformis c-PGA also depends on the concen-
tration of Co2+ and Zn2+. Other researchers have also
confirmed the dependence of the enantiomeric composi-
tion of c-PGA on Mn2+ in both B. licheniformis and B.
subtilis (Cromwick & Gross, 1995a; Wu et al., 2006).
c-PGA polymerization
In the case of B. anthracis, the genes involved in c-PGA
synthesis lie on a large plasmid, as opposed to other Bacillus
species where the genes are present on the chromosome
(Ashiuchi et al., 2001a; Shih & Van, 2001).
When c-PGA is surface associated (as in the case of B.
anthracis), cap (capsule) genes are required for its
production. However, for c-PGA that is released, the pgs
(polyglutamate synthase) genes come into action (Candela
& Fouet, 2006). Both the cap and pgs gene sets have at least
four genes: capB, C, A and E or pgsB, C, A and E (Fig. 3).
The pgsBCA genes of B. subtilis IFO3336 (B. natto) are
homologous to the capBCA genes of B. anthracis (Makino
et al., 1989; Shih & Van, 2001). pgsBCA has been identified
as the sole machinery responsible for c-PGA synthesis in
Bacillus species. To prove this, Sung et al. (2005b)
Direct/indirect  
conversion  
L-Glutamic acid 
D-Glutamic acid 
g-DL-PGA
 PgsB
L-Glutamic acid 
L-Glutamine 
Culture medium 
Oxaloacetate Citric acid 
a-KG 
TCA  
NH3
PgsAA 
PgsC PgsE
Fig. 2. A proposed pathway for the synthesis
of c-PGA. a-KG, a-ketoglutaric acid; PGS,
polyglutamate synthase. Adapted from Ho et al.
(2006), Buescher & Margaritis (2007) and Shih
& Wu (2009).
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disrupted pgsBCA genes in B. subtilis (chungkookjang)
creating pgsBCA-null mutants incapable of c-PGA produc-
tion. In contrast, Urushibata et al. (2002a) are of the
opinion that only pgsB and pgsC are required for the
production of c-PGA. The role of pgsE in the production of
c-PGA is dispensable since pgsB, pgsC and pgsAA at high
concentrations were able to form a complex capable of
producing c-PGA even in the absence of pgsE (Candela
et al., 2005). On the contrary, Yamashiro et al. (2011)
found pgsE to be essential in c-PGA production as its
introduction into the production medium in the presence
of Zn2+ tripled the production rate of c-PGA from B.
subtilis (chungkookjang). Candela et al. (2005) showed that
CapE (a 47 aa peptide) is also responsible and essential for
the production of c-PGA as it appeared to interact with
CapA. The unique membrane-bound PgsBCA complex is
highly unstable and hydrophobic, which makes isolation of
this complex challenging.
The mechanism of polymerization has been shown to be
dependent on ATP. The phosphoryl group of ATP is first
transferred to a terminal carboxyl group of elongated c-
PGA through substrate-dependent ATP hydrolysis (Sung
et al., 2005b). Then, due to a nucleophilic attack of an
amino group of glutamic acid on the phosphorylated
carboxyl group, an amide linkage is formed. This reaction
continues to polymerize c-PGA at the active site of the
synthase complex (PgsBCA). PgsB and PgsC together form
most parts of the complex’s catalytic site, whereas PgsA
seems to remove the elongated chain from the active site so
that the next monomer can be added and may also be
involved in transporting c-PGA (Ashiuchi et al., 2001b;
Urushibata et al., 2002a). Activity of PgsBCA was found to
be dependent on Mg2+ (Ashiuchi et al., 2004). Trans-
portation of c-PGA outside the cell could be facilitated by a
less compact cell membrane with shorter phospholipids
(Buescher & Margaritis, 2007).
c-PGA regulation
c-PGA synthesis in B. subtilis (natto) is thought to be
regulated by the ComP–ComA signal transduction system
(Tran et al., 2000). Stanley & Lazazzera (2005) further
identified a two-part system DegS–DegU, DegQ and SwrA
as unusual regulators of c-PGA production in addition to
ComPA. The regulatory effects of DegSU, DegQ and
ComPA seem to be transcriptional in response to quorum
sensing, osmolarity and phase variation signals, whilst that
of SwrA seems to be post-transcriptional (Stanley &
Lazazzera, 2005). Osera et al. (2009) examined the relation-
ship between SwrA and DegU, and discovered that the
presence of both SwrA and phosphorylated DegU (DegU-P)
is required to fully activate the pgs operon and in turn c-PGA
production as the effect of either gene on both pgs
transcription and c-PGA production is negligible. In contrast,
Ohsawa et al. (2009) showed that a high level of DegU-P can
directly activate pgs expression in place of swrA and high
levels of degQ, but still found swrA necessary for c-PGA
production under certain experimental conditions.
To identify the role of DegQ in c-PGA synthesis, the degQ
gene was knocked out in B. subtilis (natto), and suppressor
mutants capable of producing c-PGA synthesis in the
absence of degQ were isolated and used (Do et al., 2011).
This was compared with domestic strain B. subtilis 168,
which is unable to produce c-PGA due to low transcription
of the biosynthetic pgs operon even though it has a higher
genetic competency than the wild strain B. subtilis (natto)
(Stanley & Lazazzera, 2005; Osera et al., 2009). Do et al.
(2011) found that an alteration in degQ drastically
prevented the synthesis of c-PGA in B. subtilis (natto) and
downregulated the production of degradation enzymes,
which is in line with the report of Stanley & Lazazzera
(2005). The degQ gene of B. subtilis (natto) is therefore
important for the synthesis of c-PGA (Do et al., 2011).
c-PGA degradation
A number of enzymes have been shown to be associated
with the degradation of c-PGA. c-Glutamyl-transpeptidases
(GGT) are enzymes that breakdown the transfer of a c-
glutamyl group from a donor species to acceptor (peptides
and amino acids) species by developing an intermediate
c-glutamyl enzyme in a transpeptidation reaction (Morelli
et al., 2014). The enzyme has the ability to perform exo-
hydrolase activity towards c-PGA, and the released glu-
tamic acid is used by the bacterium as a source of carbon
and nitrogen (Kimura et al., 2004; Morelli et al., 2014).
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Fig. 3. Schematic representation of c-PGA synthesis complex: the
genetic setup required for c-PGA synthesis when it is detached (B.
subtilis and B. licheniformis) and when it is attached (B. anthracis).
Adapted from Candela & Fouet (2006).
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pgdS (also pgsS) is located downstream and in the same
orientation as the pgsBCA operon (Ashiuchi et al., 2003a;
Suzuki & Tahara, 2003; Buescher & Margaritis, 2007). It is
known to encode the enzyme c-glutamyl-hydrolase (PgsS),
which is responsible for c-PGA degradation and cleaves c-
PGA between two D-glutamates (Ashiuchi et al., 2003b;
Candela & Fouet, 2006).
CapD is a part of the GGT family and is required for the
covalent anchoring of c-PGA to the peptidoglycan as well
as acting as a depolymerase (Candela & Fouet, 2005). CapD
cleaves the c-PGA and transfers it to either an acceptor
molecule or H2O, resulting in transpeptidation or hydrol-
ysis, respectively (Candela et al., 2014). As c-PGA can be
either anchored to the bacterial surface or released, whilst
CapD catalyses the anchorage of c-PGA to peptidoglycan,
PgsS catalyses the release of c-PGA (Candela & Fouet, 2006).
The strains that have pgsBCA, but do not produce c-PGA, do
so because the genes are not translated and not because an
inactive gene product is produced (Urushibata et al., 2002b).
Yao et al. (2009) investigated the presence and activity of c-
PGA depolymerase enzyme in B. subtilis NX-2, which is
responsible for the depolymerization of c-PGA in batch
culture. The enzyme was seen to be active extracellularly in
the culture and was shown to be an endo-hydrolase. The
gene encoding the enzyme was ywtD (pgsS). The YwtD
protein was obtained in purified form after the gene was
cloned and expressed in E. coli. The enzyme was active over
a temperature range of 30–40 uC and a pH range of 5–8. At
the optimal pH and temperature (5 and 30 uC respect-
ively), a reduction in c-PGA molecular mass was observed
from 1000 to 20 kDa and dispersity decreased as a function
of depolymerization time. The enzyme was also seen to be
active extracellularly during the late stationary phase. The
study demonstrated a mild method for controlled reduction
of molecular mass, and could be used as a better alternative
to physical and chemical methods of degradation.
Conformation and enantiomeric composition of
c-PGA
c-PGA can exist in different conformational states.
Depending on the environmental conditions, c-PGA can
exhibit five different conformations: a-helix, b-sheet, helix-
to-random coil transition, random coil and enveloped
aggregate (Ho et al., 2006). The conformational state of c-
PGA can change depending on a number of factors, such as
pH, polymer concentration and ionic strength. It has been
shown that c-PGA purified from B. licheniformis can exist
in different conformational states depending on the con-
centration of c-PGA and the pH of the solution (He et al.,
2000). At low concentration (0.1% w/v) and pH,7.0, PGA
adopts a conformation based largely on a-helices, whereas
a b-sheet-based conformation predominates at higher pH
(Bhat, 2012). The b-sheet conformation seems to expose
the negative charges of c-PGA very efficiently. c-PGA
conformation is sensitive to small changes in specific
factors, e.g. changes in PGA side-chain ionization can have
a pronounced effect on the conformation (Shih & Van,
2001; Tiffany & Krimm, 1969; Bhat, 2012).
c-PGA also varies in enantiomeric composition (Table 1).
The enantiomeric composition of c-PGA determines how
c-PGA is extracted after fermentation. If c-PGA contains
only L or D enantiomers, then it dissolves in ethanol.
However, if L and D forms are in equimolar amounts, then
c-PGA precipitates in ethanol (Candela & Fouet, 2006).
Optimization to determine the effect of the enantiomeric
composition of c-PGA on its behaviour and efficacy for a
specific application is necessary. When c-PGA with different
enantiomeric compositions was tested for its antifreeze
properties, it was seen that the antifreeze activity of c-PGA
was not affected by its enantiomeric composition, but only
by its molecular mass (Shih et al., 2003). The antifreeze
property was seen to be affected by the concentration of cations
in the order of Mg2+&Ca2+#Na+&K+ (Bhat, 2012).
Culture conditions seem to have an impact on the
enantiomeric composition and molecular mass of c-PGA,
both of which can alter its properties (Rehm, 2009). It
would be interesting to see how these properties affect
specific applications. Knowledge of the conformational
state of c-PGA is therefore essential when it is used in
medical/food applications as it is known that a small
change in environmental conditions can change the prop-
erties of c-PGA to a large extent.
Production of c-PGA by microbial fermentation
Much research has gone into the production of c-PGA
from bacterial fermentation. When a-PGA is produced
synthetically, the product has a molecular mass of
,10 kDa, which limits its application. However, when
PGA is produced from bacteria (c-PGA), it has a molecular
mass .10 kDa and usually ranges from ~100 to
.1000 kDa (Richard & Margaritis, 2003; Park et al.,
2005; Bajaj et al., 2009).
Although the microbial production of c-PGA has since
been established, the cost of production, which ultimately
affects the market price (£137 per 100 mg high-purity
sodium salt c-PGA; Sigma Aldrich) of the polymer, is
presently very high and this is a major limitation to the
widespread application of the polymer. Based on this, most
research on microbial production of c-PGA is focused on
the optimization of growth conditions with the potential to
produce a high yield, specific enantiomeric composition
and desired molecular mass of c-PGA at reduced cost. The
medium used to produce c-PGA by various bacteria is
crucial because it directly affects the properties of c-PGA. It
has been shown, for instance, that different concentrations
of NaCl in the medium yield c-PGA with different
molecular masses (Birrer et al., 1994). Birrer et al. (1994)
also studied the effect of ionic strength on c-PGA
production by B. licheniformis ATCC 9945a. When the
NaCl concentration in the medium was increased from 0 to
4%, the molecular mass of the resultant c-PGA increased
c-PGA: production, properties and applications
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by a factor of 1.8 (from 1.26106 to 2.26106 Da). High-
molecular-mass c-PGA is very promising for various
industrial applications. However, it is generally diverse in
its molecular structure, and during the fermentation it is
co-produced with different polysaccharides and other
biopolymers. Production of c-PGA from B. subtilis (natto)
with a molecular mass .26106 Da has proved to be
challenging for various reasons: c-PGA synthesis or
elongation is sometimes coupled with degradation of c-
PGA towards the later stages of fermentation and the PGA
synthase complex itself is not stable. However, B. subtilis
(chungkookjang) cultivated in a medium with a high
concentration of ammonium sulphate has been found to
produce super-high-molecular-mass c-PGA without the
aforementioned problems (Park et al., 2005). The high-
molecular-mass c-PGA averaging 26106 Da was obtained
without the presence of any byproducts and was richer in
L-glutamate than its D enantiomer. Park et al. (2005) also
managed to isolate c-PGA which had a molecular mass
.26106 Da, but it was difficult to accurately measure
such a high-molecular-mass c-PGA. It was thought to be
~76106 Da.
According to Shih & Van (2001), c-PGA-producing
bacteria have been divided into two groups depending
upon their nutrient requirement for c-PGA production –
those that require L-glutamic acid in the medium and those
that do not require L-glutamic acid. The L-glutamic-acid-
dependent bacteria include B. subtilis (chungkookjang)
(Ashiuchi et al., 2001a), B. licheniformis 9945a (Birrer
et al., 1994) B. subtilis CGMCC 0833 (Wu et al., 2010), B.
licheniformis NK-03 (Cao et al., 2010) and B. subtilis
(natto) ATCC 15245 (Bhat et al., 2013), whilst the non-L-
glutamic-acid-dependent producers include B. subtilis C1
(Shih et al., 2005), B. amyloliquefaciens LL3 (Cao et al.,
2011) and B. subtilis C10 (Zhang et al., 2012). For L-
glutamic-acid-dependent bacteria, the PGA yield increases
with an increase in the L-glutamic acid concentration in the
medium. However, these bacteria can produce c-PGA even
in the absence of exogenously supplied L-glutamic acid due
to the resource of L-glutamic acid obtained through the
de novo pathway (Kunioka & Goto, 1994; Buescher &
Margaritis, 2007). The L-glutamate-independent producers
are more desirable for industrial c-PGA production than
the glutamate-dependent producers due to their low cost of
production and simple fermentation process (Cao et al.,
2011). However, their industrial utilization is limited due
to lower c-PGA productivity compared with those of
L-glutamate-dependent producers. This has led to the
development of genetically engineering non-glutamate-
dependent producers such as B. amyloliquefaciens NK-1
(Feng et al., 2014) as well as laboratory strains such as B.
subtilis MA41 (Ashiuchi et al., 2006), E. coli (Cao et al.,
2013) and B. subtilis 168 (Scoffone et al., 2013) for high c-
PGA productivity.
Production with Bacillus species
B. licheniformis
B. licheniformis has been widely used for the production of
c-PGA. B. licheniformis 9945a (NCIM 2324) is a prominent
strain that has been used for c-PGA production. As
mentioned earlier, efforts have been made to optimize
production of c-PGA with the aim to obtain maximum
yield. Bajaj et al. (2008) enhanced the production of c-PGA
using B. licheniformis NCIM 2324 in solid-state fermenta-
tion. Using the ‘one factor at a time’ method, they
investigated the effect of solid substrates, moisture content,
pH, carbon and nitrogen sources, amino acids, and TCA
cycle intermediates on the production of c-PGA. Their
optimized media gave a maximum c-PGA yield of
98.64 mg (g dry solids)21 in solid fermentation.
Bajaj et al. (2009) also optimized the production of c-PGA
with B. licheniformis NCIM 2324 using the ‘one factor at a
time’ method. The optimum nutrient concentrations were
devised with the help of response surface methodology.
These were then tested experimentally. The yield obtained
Table 1. Enantiomeric composition of PGA-producing organisms
c-PGA producer PGA composition (%) Reference
D-Glutamate L-Glutamate
Bacillus anthracis 100 – Hanby & Rydon (1946)
Bacillus subtilis ATCC 9945a (now Bacillus
licheniformis 9945a)
~10–100* ~10–90* Thorne & Leonard (1958)
Bacillus megaterium 30 70 Sung et al. (2005b)
Bacillus subtilis 70 30 Ashiuchi et al. (2003a)
Bacillus chungkookjang 70 30 Sung et al. (2005b)
Staphylococcus epidermidis 40 60 Kocianova et al. (2005)
Natrialba aegyptiaca – 100 Sung et al. (2005b)
Bacillus subtilis BS 62 60 40 Choi et al. (2004)
Bacillus licheniformis A35 80–83* 17–20* Cheng et al. (1989)
*Dependent on the concentration of Mn2+.
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with the devised medium (in g l21: glycerol, 62.4; citric
acid, 15.2; ammonium sulphate, 8.0; L-glutamic acid, 20)
was 26.12 g l21 as opposed to the basal medium (5.27 g
l21). The molecular mass of c-PGA thus obtained was
2.16105 Da.
Based on the above work, Bajaj & Singhal (2009) developed
a process that achieved a productivity of 35.75 g c-PGA l21
using B. licheniformis NCIM 2324. This is the highest
productivity of c-PGA obtained with the help of any strain
of B. licheniformis in submerged fermentation available
thus far. This was achieved by feeding B. licheniformis
NCIM 2324 with 0.07 g L-glutamine l21 and 1.46 g a-
ketoglutaric acid l21 (which are metabolic precursors for c-
PGA production), in addition to the basal medium. The
yield of c-PGA of 35.75 g l21 was in contrast to 26.12 g l21
when no metabolic precursors were added. The added
precursors helped in the better utilization of L-glutamic
acid.
B. licheniformis A13, an exogenous glutamate-independent
producer, presented a c-PGA yield of 28.2 g l21 in an
optimized medium (g l21: glucose, 50; NH4Cl, 3; yeast
extract, 2; MgSO4.7H2O, 0.8; NaCl, 0.8; CaCl2.2H2O,
0.00084; K2HPO4, 6.4; FeSO4.4H2O, 0.006; 0.1 ml trace
element solution and 25 ml culture volume) devised using
the Plackett–Burman design after 72 h of inoculation
(Mabrouk et al., 2012). Results showed that yeast extract
and medium volume were the two factors affecting c-PGA
production.
The Plackett–Burman experimental design was also used to
evaluate the culture requirements for B. licheniformis SAB-
26 (Soliman et al., 2005). Fifteen variables were tested for
their effect on c-PGA production, of which KH2PO4,
K2HPO4, (NH4)2SO4 and casein hydrolysate were the most
significant. When L-glutamic acid was used as the nitrogen
source, the production of c-PGA was repressed. Hence, B.
licheniformis SAB-26 could be classified as a glutamate-
independent c-PGA producer. A yield of 33.5 g l21 was
obtained when the bacteria were grown on the optimized
medium, which was three times more than when grown on
basal medium.
B. subtilis
Bovarnick (1942) first showed that c-PGA is freely secreted
into the medium after fermentation of B. subtilis. Following
this, considerable research has been carried out into the
production of c-PGA using B. subtilis. More strains of B.
subtilis have been investigated for the production of c-PGA
than of B. licheniformis.
c-PGA production was recently evaluated by Scoffone et al.
(2013). This was done by knocking out pgdS and ggt (genes
for two important c-PGA-degrading enzymes) in the labor-
atory strain B. subtilis 168. The effects of single mutations
(either pgdS deletion or ggt deletion) and double mutation
(both pgdS and ggt deletion) on c-PGA production were
assessed. Results revealed that single mutations had no
significant improvement on c-PGA yield, whereas a
twofold increase (.40 g l21) was observed in the double-
mutant strain compared with the WT strain. However,
number average molecular mass and weight average
molecular mass of c-PGA produced by double-mutant
strains were lower compared with those of single-mutant
strains and the WT strain. The pgdS mutant strain
presented the highest molecular mass (.36106 Da),
probably due to reduced endo-degradation activities.
High-yield, cost-effective and large-scale production of c-
PGA from B. subtilis ZJU-7 (B. subtilis CGMCC1250) has
been reported by Huang et al. (2011). Their findings
showed that 40 g yeast extract l21, 30 g L-glutamate l21
and 20 g initial glucose l21 as well as keeping the glucose
concentration in the range of 3–10 g l21 through a fed-
batch approach greatly improved the production of c-PGA
1.4- to 3.2-fold compared with that in batch fermentation.
An overall c-PGA concentration of 101.1 g l21 and a
productivity of 2.19 g l21 were recorded.
Solid-state fermentation of B. subtilis CCTCC202048 was
optimized for the production of c-PGA by Jian et al.
(2005). Maximum c-PGA production [83.61 g (kg dry
solids)21] was obtained when both soybean cake powder
and wheat bran were used as mixed substrates in a ratio of
11 : 9 (w/w) in addition to glutamate (40.14 g kg21), citric
acid (18.50 g kg21), NH4NO3 (20.05 g kg
21) andmineral salts
(MgSO4.7H2O, CaCl2.2H2O, FeCl3.6H2O and MnSO4.H2O).
Solid-state fermentation could prove to be useful for the large-
scale production of c-PGA owing to high productivity and low
production costs.
Shih et al. (2005) produced a novel glycerol-c-PGA
derivative using B. subtilis C1 without L-glutamate in the
medium (Shih et al., 2005). B. subtilis C1 was dependent on
citric acid and glycerol. If either of these was absent in
the medium, production of c-PGA was negligible. The
molecular mass of the conjugate (16107 Da) was higher
than the super-high-molecular mass c-PGA produced by
Park et al. (2005) owing to the presence of glycerol. The
ratio of c-PGA to glycerol in the conjugate was 10 : 1. The
conjugate had a higher concentration of D-glutamic acid
units (97%) than L-glutamic acid units. Interestingly,
Mn2+ did not seem to affect the enantiomeric composition
of the glycerol-c-PGA conjugate.
In contrast, Wu et al. (2006) showed that Mn2+ affected
the stereochemical and enantiomeric composition of c-
PGA produced with B. subtilis NX-2. When the concen-
tration of Mn2+ was varied from 0 to 0.09 g l21, the
proportion of D-glutamate increased from 18 to 77%.
Mn2+ seemed to affect the stereochemical properties of c-
PGA by altering the activity of glutamate racemase.
Other bacteria
The c-PGA synthase genes pgsBCA and racE from an L-
glutamate-dependent c-PGA producer B. licheniformis NK-
03 and a non-L-glutamate-dependent c-PGA producer B.
c-PGA: production, properties and applications
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amyloliquefaciens LL3 were cloned and co-expressed in
E. coli JM109 for evaluation of c-PGA productivity (Cao
et al., 2013). The results showed that pgsB and pgsC of
both strains are highly similar with 93.13 and 93.96%
resemblance, whilst the pgsA and racE presented 78.53
and 84.5% similarity, respectively. The results further
showed that the four engineered strains primarily pro-
duced c-PGA in both glucose and L-glutamate medium
after culturing for 24 h. The PgsBCA developed from B.
amyloliquefaciens LL3 seemed to possess better catalytic
activity than that of B. licheniformis NK-03 irrespective of
the harbouring vector as the quantity of c-PGA produced
by B. amyloliquefaciens LL3-pgsBCA was higher than that
by B. licheniformis NK-03-pgsBCA. There was significant
improvement in productivity and D-isomer content of c-
PGA from B. amyloliquefaciens LL3-derived PgsBCA and
RacE and B. licheniformis NK-03-derived PgsBCA and
RacE than in c-PGA from B. amyloliquefaciens LL3-derived
PgsBCA and B. licheniformis NK-03-derived PgsBCA,
showing that the incorporation of racE enhanced the
productivity of c-PGA as well as its D-isomer.
In order to avoid the addition of exogenous L-glutamic acid,
B. subtiliswas co-cultured with Corynebacterium glutamicum
using glucose and sucrose as a mixed carbon source, and this
turned out to be helpful in reducing the fermentation time
and production cost (Xu et al., 2005). The average molecular
mass of c-PGA thus produced was 1.246106 Da.
B. anthracis is known to produce a pure D enantiomer of c-
PGA (Zwartouw & Smith, 1956). The prominent difference
in the mechanism of production of B. anthracis compared
with other Bacillus species is that it does not secrete c-PGA
into the medium, but instead, it is peptidoglycan bound.
This makes the recovery and purification procedure (which
involves autoclaving and autolysis of cells) tedious. More
importantly, industrial production of c-PGA from B.
anthracis is not viable owing to its toxicity. In fact, the
anchored c-PGA is responsible for the non-immunogenic
capsule of B. anthracis, which has been associated with
the lethal toxin (Ezzell et al., 2009). Hence, to render B.
anthracis immunogenic, its cap gene responsible for the
anchoring of c-PGA onto its surface needs to be targeted
(Candela & Fouet, 2006).
It was shown that Bacillus thuringiensis sv. Monterrey strain
BGSC 4AJ1 produced a c-PGA capsule similar to that of B.
anthracis (Cachat et al., 2008). B. thuringiensis sv. Monterrey
strain BGSC 4AJ1 and B. anthracis (Ames) had four
common alleles, gmk-1, pta-1, pur-1 and tpi-1, whilst the
three other alleles, glpF-57, ilvd-52 and pycA-52, differed by
2, 2 and 3 nt respectively. The c-D-PGA-producing genes
bear similarity with those of B. anthracis and are present on a
plasmid (pAJ1-1). Discovery of a c-PGA capsule in this
strain of B. thuringiensis could indicate the ability of the
bacteria to be pathogenic under certain conditions.
The indispensable pgsBCA complex was also introduced
into tobacco leaves via Agrobacterium infection (Tarui et al.,
2005). c-PGA production was only seen in plant tissue
where all three pgsBCA genes transferred successfully and
600 mg c-PGA (g leaf material)–1 was obtained.
Characterization of c-PGA
Molecular characterization of c-PGA is essential in order to
evaluate its properties and hence its potential areas of
application.
Molecular mass determination
Gel permeation chromatography (GPC) is the most
commonly used method for determining the molecular
mass of c-PGA. GPC uses a range of mobile phases and
calibrates against standards of diverse molecular masses
(Birrer et al., 1994). The molecular mass of c-PGA is
important for understanding its function (Sung et al.,
2005b). The molecular mass of c-PGA produced by Bacillus
species ranges from 105 to 106 Da (Shih & Van, 2001)
and differs depending on the application for which it is
required. Molecular mass reduction can be an important
step in the production of c-PGA for drug delivery
applications. Different techniques used for this purpose
include ultrasonic degradation, alkaline hydrolysis, altera-
tion of medium composition and microbial or enzymic
degradation (Shih & Van, 2001). Ultrasonic degradation in
particular was shown to be an effective method to reduce
both the molecular mass and the dispersity of naturally
produced PGA without disturbing the chemical consti-
tution of the polymer (Graciela et al., 2000). Richard &
Margaritis (2006) carried out in situ depolymerization of c-
PGA in the cell-free fermentation broth of B. subtilis IFO
3335. The molecular mass, when measured using GPC and
intrinsic viscosity correlations, reduced from ~46106 to
5.56104 Da over a period of 144 h. As with the study of
Yao et al. (2009), the dispersity of c-PGA decreased as a
function of hydrolysis time. Enzymic degradation seems to
be a better method to obtain c-PGA of the required
molecular mass in a controlled fashion.
Amino acid analysis
The detection of only glutamic acid in amino acid and TLC
analysis indicates the purity of c-PGA (Shih & Van, 2001).
For amino acid analysis of c-PGA, purified c-PGA is
hydrolysed with 6 M HCl at 100 uC for a number of hours
(depending on the amount of c-PGA) in an airtight tube,
followed by the removal of residual HCl by evaporation
and then the hydrolysed product is dissolved in distilled
water before analysing the amino acid contents by TLC
(Yokoi et al., 1995). Shih et al. (2001) purified c-PGA by
hydrolysis with 6 M HCl at 110 uC for 24 h in a closed and
evacuated tube, and analysed the product using an amino
acid analyser. TLC was then carried out on a cellulose plate
with solvent systems of butanol/acetic acid/water (3 : 1 : 1,
w/w/w) and 96% ethanol/water (63 : 37, w/w), and amino
acids were identified by spraying with 0.2% ninhydrin in
acetone (Yokoi et al., 1995).
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NMR spectroscopy
1H- and 13C-NMR spectroscopy are usually performed to
determine the homogeneity and degree of esterification of
c-PGA (Birrer et al., 1994; Borbely et al., 1994). Chemical
shifts from resulting NMR spectra are measured relative to
known standards.
Fourier transform-IR spectroscopy
The Fourier transform-IR spectroscopy technique which
emplys an IR absorption spectrum is used for product
identification. The method produces IR spectra of c-PGA
with peaks corresponding to specific bonds in the
compound. According to Ho et al. (2006), the IR spectra
of c-PGA (free acid form) and c-polyglutamate salts in KBr
pellets indicate distinctive strong amide absorption at
~1620–1655 cm21, a weaker carbonyl C5O absorption
at ~1394–1454 cm21, a strong hydroxyl OH absorption at
~3400–3450 cm21 and a characteristic strong C–N groups
absorption in the range from 1085 to 1165 cm21. The
absorption peaks between 2900 and 2800 cm21 are
characteristic of aliphatic N–H stretching, whilst those
around 1600–1660 and 1390–1450 cm21 exhibit character-
istics of amide groups and C5O groups, respectively.
Applications of c-PGA
c-PGA is an extremely important substance that has been
exploited for a wide array of useful applications due to its
unique properties. It is biodegradable, edible and non-toxic
for humans, which itself is a prerequisite for being used for
human benefit.
Medical applications
This section will describe some important potential
medical applications that have exploited c-PGA.
Optimization of c-PGA for use in drug delivery applica-
tions is a crucial step in making this technology applicable.
Molecular mass has been found to be a decisive factor on
which the drug delivery properties of c-PGA depend.
Polymers of different molecular masses are required to
control a drug’s release into tissue. In this regard, it was
found that the molecular mass of c-PGA is often higher
than that required for drug delivery applications (Richard
& Margaritis, 2006). The molecular mass of c-PGA
required for conjugation with the drug paclitaxel (Taxol),
for example, has been determined to be 36104–66104 Da
(Li et al., 1998). Li et al. (1998) designed a PGA–paclitaxel
conjugate by covalent bonding of natural paclitaxel to PGA
in order to improve the stability and antitumour efficiency
of paclitaxel, and to offer a water-soluble paclitaxel. The
PGA–paclitaxel conjugate showed significantly better anti-
tumour activity against murine and human tumour
xenografts, including breast and ovarian cancers in animal
models, than did regular paclitaxel. This was thought to be
due to the uptake of the PGA–paclitaxel conjugate by
tumour cells being about fivefold greater than that of
paclitaxel when comparable doses were used. In contrast to
paclitaxel, in vitro studies with the PGA–paclitaxel
conjugate showed that it supports neither tubulin poly-
merization nor the growth and survival of a Taxol-
dependent CHO cell line (Li et al., 1998).
Singer (2005) also devised a conjugate of c-PGA and
paclitaxel called paclitaxel poliglumex. Paclitaxel poliglu-
mex is a macromolecular taxane designed to improve
the safety and efficiency of paclitaxel by enhancing its
pharmacokinetic profile as well as offering a water-soluble
substitute for the standard paclitaxel design. Preclinical
developments in animal tumour models showed that
paclitaxel poliglumex is as effective as regular paclitaxel
and is associated with longer tumour exposure to active
drug and systemic exposure is reduced. Paclitaxel poliglu-
mex presents a number of advantages over standard
paclitaxel, including solubility in water, stability in plasma
that relates to a reduced systemic exposure to free paclitaxel,
smaller volume of distribution, longer distribution and
elimination phases of paclitaxel poliglumex’s pharmaco-
logical profile, and increased tumour selectivity via
enhanced accumulation and retention in tumour tissue. In
contrast to non-degradable polymers, L-glutamic acid, the
catabolic product of c-PGA, can enter normal cellular
metabolism and is not excreted by the kidney (Singer, 2005).
Kim et al. (2007) have shown that administering c-PGA
with a molecular mass as high as 26106 Da orally induces
significant natural killer (NK)-cell-mediated antitumour
immunity in mice bearing major histocompatibility
complex class I-deficient tumours (Kim et al., 2007). The
mechanism underlying the antitumour immunity was seen
to be due to the activation of NK cells by c-PGA rather
than a direct cytotoxic effect. Their results showed that c-
PGA (26106 Da) is as good as or a better stimulator of
antitumour effects against B16 tumours in C57BL/6 mice
than b-glucan (curdlan) – an immunomodulating anti-
tumour agent known to activate NK cells. This research
suggests the potential use of c-PGA in cancer immu-
notherapy.
Ryu et al. (2011) developed nanoparticles (NPs) composed
of c-PGA coupled with L-phenylalanine (c-PGA-Phe NPs).
They explored the possibility of these c-PGA-Phe NPs both
in vitro and in vivo in the treatment of retinal diseases. c-
PGA-Phe NPs with Texas red-labelled ovalbumin were
used to investigate the dynamics of NPs in the eye, whilst
those containing dexamethasone were used to investigate
their potential in in vivo immunosuppressive treatment of
macrophages and microglia in several pathological retina
disorders (Ryu et al., 2011). Results suggested that c-PGA-
Phe NPs are suitable, particularly under pathological
conditions, for regulating inflammatory phagocytic cells
in the retina. Additionally, results revealed that c-PGA-Phe
NPs can be used as a carrier for long-term drug delivery in
the damaged retina. c-PGA-Phe NPs possess important
advantages over steroids such as triamcinolone acetate,
c-PGA: production, properties and applications
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Table 2. Applications of c-PGA and its derivatives
Field Application Function Reference(s)
Wastewater
treatment
Biopolymer flocculant c-PGA produced by B. subtilis R 23 showed a high flocculating activity
that could be further enhanced by the addition of cations.
Bajaj & Singhal
(2011)
Efficient flocculation of various organic and inorganic compounds was
demonstrated by c-PGA produced by B. licheniformis CCRC 12826.
Shih et al. (2001)
Heavy metal removal c-PGA covalently incorporated into microfiltration membranes via
attachment to their membrane pore surfaces exhibited super-high
heavy metal sorption ability.
Bhattacharyya
et al. (1998)
c-PGA was found to bind and efficiently remove .99.8% of lead ions
from water via a suitable low-pressure ultrafiltration technique.
Hajdu et al.
(2012)
Dye removal c-PGA (9.96105 Da) could be used effectively to remove basic dyes
from aqueous solution. It was found that 98% of the dye adsorbed on
c-PGA could be recovered at pH 1, which facilitates the reuse of spent c-PGA.
Inbaraj et al.
(2006)
Medicine Metal chelator c-PGA-coated super paramagnetic iron oxide NPs demonstrated high
heavy metal removal efficiency from simulated gastrointestinal fluid
and a metal solution.
Inbaraj & Chen
(2012)
Drug carrier/deliverer c-PGA with covalently attached cisplatin was shown to reduce the toxicity
of cisplatin, whilst efficiently decreasing the tumour size of xenografted
human breast tumours in nude mice as well as lengthen the survival of
nude mice grafted with Bcap-37 tumour cells.
Ye et al. (2006)
A macromolecular conjugate of paclitaxel and c-L-PGA called paclitaxel
poliglumex exhibited outstanding benefits over conventional paclitaxel.
Paclitaxel poliglumex was accumulated in tumour tissue, where it gradually
discharged the active agent paclitaxel.
Singer (2005)
Tissue engineering A c-PGA/chitosan composite biomaterial demonstrated potential application
in tissue engineering as it is more hydrophilic and cytocompatible than
conventional chitosan matrices.
Hsieh et al. (2005)
A PEC of chitosan and c-PGA demonstrated potential application in wound
dressing. The complex presented sufficient moisture content and showed
good mechanical properties, which would allow the dressing to be easily
removed from the wound surface without destroying renewed tissues.
Tsao et al. (2011)
Biological adhesive A mixture of gelatin and c-PGA aqueous solution which resulted in the
formation of a hydrogel in the presence of water-soluble carbodiimide
demonstrated better lung adhesion and air-leak sealing than conventional
fibrin glue.
Otani et al. (1999)
Calcium absorption Administration of c-PGA increased calcium absorption in the intestine in
post-menopausal women by inhibition of the formation of an insoluble
calcium complex with phosphate. Can be potentially used for treatment
of bone disorders.
Tanimoto et al.
(2007)
Food industry Food supplement/
osteoporosis-
preventing agent
Natto mucilage containing c-PGA greatly improved calcium solubility
in vitro and in vivo in rats as well as the calcium content of their bones.
Tanimoto et al.
(2001), Ho et al.
(2008)
Texture enhancer The addition of c-PGA to wheat bread reduced its hardness through
storage. c-PGA also enhanced the rheological and thermal properties of
wheat dough. c-PGA was demonstrated to improve the texture of sponge cake.
Shyu et al. (2008),
Shyu & Sung
(2010)
Oil-reducing agent c-PGA was demonstrated to reduce oil uptake during deep-fat frying.
c-PGA added to doughnuts showed a fivefold decrease in the amount of oil
absorbed compared with normal doughnuts. The overall appearance and
taste of the product was better than those of normal doughnuts.
Lim et al. (2012)
Cryoprotectant c-PGAs with molecular masses ,20 kDa were demonstrated to have
higher antifreeze activities than high antifreeze agents like glucose
and they do not interfere with the taste of foods.
Mitsuiki et al.
(1998)
c-PGA with a molecular mass of 257 kDa has been used as a cryoprotectant
for probiotic bacteria to improve their survival during production.
Bhat et al. (2013)
Bitterness-relieving
agent
c-PGA has been used as a bitterness-relieving agent Sakai et al. (2000)
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which has been used to effectively treat retinal disorders.
These advantages include lack of complications of steroid-
induced glaucoma and post-capsular cataract formation.
Unlike steroids, where direct application is toxic for retinal
neurons, c-PGA-Phe NPs specifically target macrophages
and microglia, thereby minimizing steroid complications
(Ryu et al., 2011).
A polyelectrolyte complex (PEC) comprising chitosan as a
cationic polyelectrolyte and c-PGA as an anionic polyelec-
trolyte was designed by Tsao et al. (2011) for wound
dressing. Results showed that the chitosan/c-PGA PECs
exhibit adequate moisture content, with c-PGA reducing
the risk of dehydration compared with regular chitosan.
Preclinical studies in animal models showed that wounds
treated with the chitosan/c-PGA PECs healed faster than
wounds given no treatment. Chitosan/c-PGA PECs showed
excellent suppression of inflammatory cells in contrast to
neat chitosan, indicating that c-PGA has an anti-inflam-
matory effect. Keratin development was more assimilated
in those wounds treated with chitosan/c-PGA PECs
compared with the neat chitosan or control. Chitosan/c-
PGA PECs were also easily taken off the wound surface
after healing without causing damage to the newly
regenerated tissue, suggesting that chitosan/c-PGA PECs
are potential materials for wound dressings.
The suppressive effect of c-PGA on the SOS response of
Salmonella typhimurium induced by several direct and
indirect mutagens has been studied and evaluated (Sato
et al., 2008). The sodium salt of c-PGA was used with a
range of molecular masses: 50, 2000, 4000, 6000 and
8000 kDa. When 3% Na-c-PGA with a molecular mass of
4000 kDa was used, 80–90% suppression was observed
irrespective of the type of chemical mutagen, and this
was better than carboxymethylcellulose (20–40%) and
xanthan gum (40–75%). The antimutagenic property of
c-PGA was shown to be dependent on the molecular mass.
c-PGAs with molecular masses of 50 and .6000 kDa did
not show any distinct antimutagenic property. It is believed
that after appropriate tests, c-PGA could be used as an
antimutagenic food additive.
Food applications
One of the naturally occurring sources of c-PGA is the
mucilage of natto (fermented soybeans), which is a
traditional food in Japan. As it is food derived, c-PGA
can be used for food applications.
The effect of c-PGA on the viability of probiotic bacteria
during freeze-drying was investigated by Bhat et al. (2013).
Results showed that 10% c-PGA was found to protect
Table 2. cont.
Field Application Function Reference(s)
Cosmetics Moisturizer c-PGA has been demonstrated to improve the qualities of skincare and
haircare products, such as exfoliating, moisturizing and removing wrinkles.
Ben-Zur &
Goldman (2007)
Agriculture Bio-control agent
and/or fertilizer
synergist
Lipopeptides and c-PGA produced by B. subtilis B6-1 using soybean and sweet
potato residues adequately repressed cucumber wilts, increased nutrient
consumption as well as increased the growth of cucumber seedlings.
Wang et al. (2008)
Others Biodegradable plastic Biodegradable plastics comprising a-radiation-cross-linked PGA or a PGA
salt as the major constituent have been reported.
Tsutomu &
Makoto (2002)
Esterified c-PGA produced by B. subtilis F2-01 was discovered to be a
good thermoplastic. Ester derivatives of c-PGA have also demonstrated
the ability to form biodegradable fibres and films, thereby eliminating
non-biodegradable polymers.
Kubota et al.
(1995), Shih &
Wu (2009)
Gene delivery A pDNA/polyethylenimine/c-PGA complex was developed and used for gene
delivery with very high transgene capability and low toxicity.
Kurosaki et al.
(2009)
Antibacterial activity Magnetite NPs coated with sodium and calcium salts of c-PGA demonstrated
antibacterial activity against Salmonella enteritidis SEM 01 compared with the
commercial antibiotics linezolid and cefaclor, and were cytocompatible.
NaPGA-NPs were also active against E. coli ATCC 8739 and Staphylococcus
aureus ATCC 10832, whilst CaPGA-NPs were active against E. coli O157 :H7
TWC 01.
Inbaraj et al.
(2011)
Inhibition of
influenza virus
c-PGA-based glycopolymers (used to inhibit influenza virus) showed higher
solubility in water and heat stability, and lower toxicity and immunogenicity,
compared with glycopolymers without c-PGA.
Ogata et al.
(2009)
Glucose sensor Needle-type glucose sensors prepared by covalent immobilization of glucose
oxidase on c-PGA film. Increased stability of the electrode to 1 month.
Yasuzawa et al.
(2011)
Treatment of
xerostomi
(dry mouth)
c-PGA promotes salivary secretion and produces a moisturizing effect. Use of
c-PGA solved problems associated with xerostomi: difficulties in speaking,
bad breath, dental caries, periodontal disease and mucosal infectious disease.
Uotani et al.
(2011)
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Lactobacillus paracasei significantly better than 10%
sucrose, which has been reported previously to offer better
protection during freeze-drying of lactobacilli compared
with trehalose and sorbitol (Siaterlis et al., 2009), and nata,
a bacterial cellulose produced by Acetobacter xylinum
(Jagannath et al., 2010).
Lim et al. (2012) investigated the effect of c-PGA on oil
absorption and moisture loss in doughnuts during deep-fat
frying. It was shown that at a frying time of 4 min and c-
PGA concentration of 1 g (100 g dough)–1, oil uptake was
reduced by fivefold in doughnuts containing c-PGA [0.2 g
(g dough)–1] compared with regular doughnuts [0.7 g (g
dough)–1]. Overall, c-PGA doughnuts had better appear-
ance and taste than regular doughnuts. c-PGA is therefore
a potential oil-reducing agent in deep-fat fried foods.
The effects of c-PGA on the viscosity, foam stability and
emulsifying properties of sponge cake batter at different
concentrations (0.05, 0.1 and 0.5 g kg21, w/w) were
explored by Shyu & Sung (2010). The addition of 0.5 g
c-PGA kg21 to sponge cake batter showed an increase in
viscosity, foam stability and emulsion stability. Sponge
cake hardness and chewiness were also decreased during
storage with the addition of c-PGA.
c-PGA was found to increase calcium absorption in vitro
and in vivo, and decrease bone loss in humans (Tanimoto
et al., 2007). c-PGA increased the bioavailability of calcium
by increasing its solubility and intestinal absorption.
The increase in calcium solubility was as a result of the
inhibition of the production of insoluble calcium phos-
phate (Tanimoto et al., 2007). Post-menopausal women
who were given a single dose of c-PGA were seen to have
better intestinal absorption. Individuals with lower basal
absorptive capacity were particularly seen to benefit from
c-PGA.
Wastewater treatment
Chang et al. (2013) investigated the capability of c-PGA-
modified superparamagnetic iron oxide NPs (c-PGA/Fe3O4
NPs) in the removal of heavy metal ions including Cr3+,
Cu2+, Pb2+ and Ni2+. The c-PGA/Fe3O4 NPs showed
outstanding removal activity for all metals and better
removal efficiency than either Fe3O4 NPs or c-PGA only,
whilst overcoming the weaknesses of using either Fe3O4
NPs or c-PGA on their own. This indicates that c-PGA has
potential applications in wastewater treatment.
c-PGA (5.86106 Da) produced from B. subtilis 2063
showed great flocculating activity indicating that c-PGA
can be a potential alternative to conventional synthetic
flocculants (known to persist in the environment) in
wastewater treatment (Bhunia et al., 2012). Similarly, Bajaj
& Singhal (2011) studied the flocculation properties of c-
PGA (6.26106 Da) derived from B. subtilis R 23. Results
indicated that c-PGA is an excellent flocculant, and can be
used in wastewater treatment plants and downstream
processing of food and fermentation industries.
Bodna´r et al. (2008) have also investigated the preparation
and characterization of novel biodegradable NPs based on
complexation of c-PGA derived from B. licheniformis 9945a
with bivalent lead ion. The prepared complex was stable in
aqueous media under low, neutral and mild alkaline
conditions. This complex is thought to have useful water
treatment applications due to its biodegradability along
with heavy metal-binding activity.
c-PGA (9.96105 Da) can be used effectively to remove
basic dyes from aqueous solution (Inbaraj et al., 2006). It
was found that 98% of the dye adsorbed on c-PGA could
be recovered at pH 1, which facilitates the re-use of spent
c-PGA. As c-PGA is non-toxic and biodegradable, the
adsorption system developed could offer eco-friendly
solutions to the dye industry.
Other applications
The applications of c-PGA in skincare products were
explored by Ben-Zur & Goldman (2007). They found that
c-PGA is a good hydrophilic humectant and has the ability
to increase the production of natural moisturizing factors
such as urocanic acid, pyrrolidone carboxylic acid and
lactic acid compared with hyaluronic acid and soluble
collagen. c-PGA has also been shown to enhance the
elasticity of the skin more than collagen and hyaluronic
acid as well as refresh and nourish the skin, making it
smoother and more desirable (Ben-Zur & Goldman, 2007).
c-PGA has been used successfully as an active ingredient in
a hyaluronidase inhibitor (Sung et al., 2005a). Hyaluron-
idase is an enzyme that degrades hyaluronic acid present in
the skin dermis. The composition was tested on 50 women
(aged 30–50 years), and was shown to maintain skin
elasticity by inhibiting the activity of hyaluronidase and
reduce allergenic reactions by inhibiting the permeability of
inflammatory cells.
Hu et al. (2008) tested whether c-PGA could be used to
induce protein crystallization in easily crystallizable proteins
(lysozyme, glucose isomerase and xylanase). Both low-
molecular-mass c-PGA (Na+ salt: 26105–46105 Da) and
high-molecular-mass c-PGA (Na+ salt: .16106 Da) were
tested, and results showed that c-PGA could indeed induce
precipitation in proteins as additives or stand-alone
precipitants.
The number of potential application for c-PGA is vast and
still increasing. Table 2 attempts to summarize the diversity
of c-PGA uses within a range of application areas.
Conclusion
c-PGA is biodegradable, edible and non-immunogenic, and
can therefore be used safely in a variety of applications that
are increasing rapidly. Knowledge of the genes and
enzymes involved in c-PGA regulation throws light on
the conditions that support c-PGA production (e.g. high
osmolarity), and this information could be used to isolate
A. Ogunleye and others
12 Microbiology 161
Downloaded from www.sgmjournals.org by
IP:  54.210.20.124
On: Mon, 21 Sep 2015 10:48:52
and screen new c-PGA-producing strains from different
sources. As different applications of c-PGA exploit dif-
ferent specific properties of c-PGA, it would be interesting
to analyse the properties of the c-PGA that would be
produced by different bacteria grown under a range of
culture conditions.
For conventional materials to be replaced with c-PGA, the
cost of production of c-PGA needs to be several tens to
hundreds times lower than at present. With this vision in
mind, a lot of work has been done with respect to the
molecular biology aspects of c-PGA production with
different organisms. A complete understanding of c-PGA
synthesis has still not been achieved, especially with regard
to the regulation of c-PGA production within the cell.
Statistical analyses of large-scale c-PGA production could
also lead to answers for cost-effective production of c-PGA.
a-PGA has been exploited widely for medical applications,
more so for sustained drug delivery. Researchers have
pointed out that there could be several advantages of using
c-PGA over a-PGA. Pure c-PGA can be obtained in large
quantities without any chemical modification step. It is not
susceptible to proteases and hence could provide better
sustained delivery of conjugated drugs in the body. Better
incorporation of drug in terms of quantity of drug
conjugated into c-PGA has been achieved. Optimization
of c-PGA with respect to molecular mass, enantiomeric
composition and conformational states is an indispensable
step in making application of c-PGA practical. Molecular
biology techniques would not only help optimize c-PGA
production for various applications, but also enable us to
understand the mechanisms by which c-PGA is effective in
numerous applications. We hope this review provides an
updated overall understanding of the concepts involved in
c-PGA synthesis and applications, and facilitates further
research on this highly useful multifunctional biomaterial.
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